Palisade bio cleared by health canada to commence phase 1 clinical study for lead program, pali-2108 for the treatment of ulcerative colitis (uc)

– company has received a no objection letter from health canada in response to submission of its phase 1 clinical trial application (cta)

PALI Ratings Summary

PALI Quant Ranking